Michael Adamzik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michael Adamzik has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Hartmuth Nowak
Ruhr University Bochum, Knappschaft Kliniken University Hospital Bochum, Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Bochum, Germany
16 shared publications - Nina Timmesfeld
Department of Medical Informatics, Biometry and Epidemiology, Ruhr University Bochum, Bochum, Germany
11 shared publications - Frank Martin Brunkhorst
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena, Jena, Deutschland
9 shared publications - Jürgen Wasem
Institute of Healthcare Management, Universität Duisburg-Essen, 45127 Essen, Germany
9 shared publications - Lars Palmowski
Ruhr University Bochum, Knappschaft Kliniken Universitätsklinikum Bochum, Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätstraße 150, Bochum, Germany, 49 02343229242
9 shared publications - Marianne Tokic
Department of Medical Informatics, Biometry and Epidemiology, Ruhr University Bochum, Bochum, Germany
9 shared publications
Latest Publications
- Open Access
- 25 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e87020
AI-Supported, Integrative Prediction of Postoperative Delirium: Protocol for the CONFUSED Study
Background: Postoperative delirium (POD) is a frequent and serious complication in older surgical patients, characterized by acute cognitive dysfunction and fluctuating levels of consciousness. POD is associated with prolonged hospitalization, long-term cognitive decline, reduced quality of life, and increased mortality. Despite its clinical relevance, the underlying pathophysiological mechanisms remain poorly understood, and reliable biomarkers for early prediction and prevention are lacking. Objective: The CONFUSED study aims to identify molecular and clinical predictors of POD by integrating clinical data with proteomic, transcriptomic, and epigenetic analyses. The primary objective is to develop predictive models for POD using multimodal data. Secondary objectives include the identification of delirium-associated genes, proteins, and epigenetic signatures, as well as the exploration of patient subgroups at increased risk for POD. Methods: CONFUSED is a prospective observational cohort study conducted at a German university hospital. Adult patients undergoing major surgery under general anesthesia will be enrolled until 100 cases of POD have been observed, which is expected to require a total sample size of approximately 200 to 300 patients. Blood samples are collected at 4 predefined time points: before premedication, immediately after surgery, and on postoperative days 2 and 5. Samples undergo comprehensive proteomic profiling, transcriptomic analysis using RNA microarrays, DNA methylation analysis, and genotyping of selected polymorphisms. Clinical data, including demographics, comorbidities, perioperative variables, medications, and delirium assessments using the Confusion Assessment Method (CAM) and CAM for the intensive care unit, are systematically recorded. Statistical analyses include univariate and multivariate methods, as well as machine learning approaches such as random forests and support vector machines, to identify relevant biomarkers and develop predictive models. The study protocol follows STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) and TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) guidelines and was approved by the responsible ethics committees. Results: The study was registered in the German Clinical Trials Register (DRKS00033854) on March 18, 2024. Recruitment started in January 2024 and is ongoing at the time of manuscript submission. As of now, 135 patients have been enrolled. Sample collection and laboratory analyses are ongoing. Data analysis began in January 2026, with first results anticipated in July 2026. Final data lock is anticipated after the completion of recruitment. Conclusions: By integrating multimodal molecular data with clinical parameters and applying advanced machine learning techniques, the CONFUSED study aims to improve the prediction and understanding of POD. The results are expected to support the development of personalized preventive strategies and contribute to improved perioperative care for patients at risk of POD.
- 25 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e87020
Open AccessAI-Supported, Integrative Prediction of Postoperative Delirium: Protocol for the CONFUSED Study
Background: Postoperative delirium (POD) is a frequent and serious complication in older surgical patients, characterized by acute cognitive dysfunction and fluctuating levels of consciousness. POD is associated with prolonged hospitalization, long-term cognitive decline, reduced quality of life, and increased mortality. Despite its clinical relevance, the underlying pathophysiological mechanisms remain poorly understood, and reliable biomarkers for early prediction and prevention are lacking. Objective: The CONFUSED study aims to identify molecular and clinical predictors of POD by integrating clinical data with proteomic, transcriptomic, and epigenetic analyses. The primary objective is to develop predictive models for POD using multimodal data. Secondary objectives include the identification of delirium-associated genes, proteins, and epigenetic signatures, as well as the exploration of patient subgroups at increased risk for POD. Methods: CONFUSED is a prospective observational cohort study conducted at a German university hospital. Adult patients undergoing major surgery under general anesthesia will be enrolled until 100 cases of POD have been observed, which is expected to require a total sample size of approximately 200 to 300 patients. Blood samples are collected at 4 predefined time points: before premedication, immediately after surgery, and on postoperative days 2 and 5. Samples undergo comprehensive proteomic profiling, transcriptomic analysis using RNA microarrays, DNA methylation analysis, and genotyping of selected polymorphisms. Clinical data, including demographics, comorbidities, perioperative variables, medications, and delirium assessments using the Confusion Assessment Method (CAM) and CAM for the intensive care unit, are systematically recorded. Statistical analyses include univariate and multivariate methods, as well as machine learning approaches such as random forests and support vector machines, to identify relevant biomarkers and develop predictive models. The study protocol follows STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) and TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) guidelines and was approved by the responsible ethics committees. Results: The study was registered in the German Clinical Trials Register (DRKS00033854) on March 18, 2024. Recruitment started in January 2024 and is ongoing at the time of manuscript submission. As of now, 135 patients have been enrolled. Sample collection and laboratory analyses are ongoing. Data analysis began in January 2026, with first results anticipated in July 2026. Final data lock is anticipated after the completion of recruitment. Conclusions: By integrating multimodal molecular data with clinical parameters and applying advanced machine learning techniques, the CONFUSED study aims to improve the prediction and understanding of POD. The results are expected to support the development of personalized preventive strategies and contribute to improved perioperative care for patients at risk of POD.
- Open Access
- 26 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e76772
Patient Benefits in the Context of Sepsis-Related AI-Based Clinical Decision Support Systems: Scoping Review
Background: Global digitalization continues to advance, extending its influence into medicine and health care systems worldwide. In recent years, substantial advancements have been made in the research and development of artificial intelligence (AI), raising questions about its potential in medicine. The integration and application of AI in intensive care medicine, particularly in sepsis treatment, presents significant potential for advancing patient outcomes and enhancing patient-relevant benefits. However, a comprehensive and systematic overview of the full spectrum of patient-relevant benefits associated with AI-based clinical decision support systems (CDSS) remains lacking. Objective: This scoping review aimed to identify and categorize evidence on patient-relevant benefits of AI-based CDSS in sepsis care. Methods: Systematic research was conducted in 4 electronic databases: MEDLINE via PubMed, Embase, the ACM Digital Library, and IEEE Xplore. In addition, a comprehensive search on the websites of relevant international organizations, along with a citation search of the included articles, was conducted. Articles were included if they (1) focused on sepsis and (2) described patient-relevant benefits of AI-based CDSS. Articles published between January 1, 2008, and March 2, 2023, were considered for inclusion. Study selection was performed independently by 2 reviewers. The manuscript was drafted in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) checklist. The analysis of the included articles was conducted using the program MAXQDA (VERBI Software GmbH), with systemization finalized in a consensus workshop. Results: A total of 3368 records were identified across the 4 databases, of which 24 met the inclusion criteria and were included in the scoping review. The additional search on international websites and in reference lists identified 6 more relevant articles, resulting in 30 included studies. Of these, 20 were quantitative, comprising 7 prospective and 13 retrospective designs. In addition, 1 qualitative study, 1 mixed methods study, 6 review articles, and 2 articles from institutional websites were included. Patient-relevant benefits were systematized in six main categories: (1) prediction, (2) earlier treatment and prioritization of high-risk patients, (3) individualized therapy, (4) improved patient outcomes (including improved Sequential Organ Failure Assessment score, reduced length of stay, and reduced mortality), (5) general improvements in care, and (6) reduced readmission rate. Conclusions: This scoping review underscores the potential of AI-based CDSS to positively impact patient-relevant benefits, particularly in sepsis care, where they demonstrate considerable promise for improving intensive care. However, the majority of the identified studies rely on retrospective database analyses. Future research should focus on validating these findings through prospective studies.
- 26 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e76772
Open AccessPatient Benefits in the Context of Sepsis-Related AI-Based Clinical Decision Support Systems: Scoping Review
Background: Global digitalization continues to advance, extending its influence into medicine and health care systems worldwide. In recent years, substantial advancements have been made in the research and development of artificial intelligence (AI), raising questions about its potential in medicine. The integration and application of AI in intensive care medicine, particularly in sepsis treatment, presents significant potential for advancing patient outcomes and enhancing patient-relevant benefits. However, a comprehensive and systematic overview of the full spectrum of patient-relevant benefits associated with AI-based clinical decision support systems (CDSS) remains lacking. Objective: This scoping review aimed to identify and categorize evidence on patient-relevant benefits of AI-based CDSS in sepsis care. Methods: Systematic research was conducted in 4 electronic databases: MEDLINE via PubMed, Embase, the ACM Digital Library, and IEEE Xplore. In addition, a comprehensive search on the websites of relevant international organizations, along with a citation search of the included articles, was conducted. Articles were included if they (1) focused on sepsis and (2) described patient-relevant benefits of AI-based CDSS. Articles published between January 1, 2008, and March 2, 2023, were considered for inclusion. Study selection was performed independently by 2 reviewers. The manuscript was drafted in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) checklist. The analysis of the included articles was conducted using the program MAXQDA (VERBI Software GmbH), with systemization finalized in a consensus workshop. Results: A total of 3368 records were identified across the 4 databases, of which 24 met the inclusion criteria and were included in the scoping review. The additional search on international websites and in reference lists identified 6 more relevant articles, resulting in 30 included studies. Of these, 20 were quantitative, comprising 7 prospective and 13 retrospective designs. In addition, 1 qualitative study, 1 mixed methods study, 6 review articles, and 2 articles from institutional websites were included. Patient-relevant benefits were systematized in six main categories: (1) prediction, (2) earlier treatment and prioritization of high-risk patients, (3) individualized therapy, (4) improved patient outcomes (including improved Sequential Organ Failure Assessment score, reduced length of stay, and reduced mortality), (5) general improvements in care, and (6) reduced readmission rate. Conclusions: This scoping review underscores the potential of AI-based CDSS to positively impact patient-relevant benefits, particularly in sepsis care, where they demonstrate considerable promise for improving intensive care. However, the majority of the identified studies rely on retrospective database analyses. Future research should focus on validating these findings through prospective studies.
- Open Access
- 15 December 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (12) , 1266
Association Between Differential Heterogeneity of Antibiotics Consumption and Share of Resistant Pathogens and Its Implication for Antibiotic Stewardship in a German Hospital Intensive Care Unit
Background: The rapid rise in antimicrobial resistance has become one of the 10 most pressing health problems worldwide in recent years. Antibiotic stewardship offers hope in the fight against antibiotic resistance, but it is currently still falling short of expectations. A better understanding of the dynamics of the interaction between antibiotic consumption and the emergence and spread of resistance is urgently needed. Methods: We discuss a simple dynamic model based on a differential equation to describe the increase in the proportion of a pathogen’s antimicrobial resistance to an antibiotic as a function of the time-dependent consumption of that antibiotic. Furthermore, we investigate the association of heterogeneity in the consumption of antibiotics with the rate of resistant pathogens. Data basis is the hospital information system and the patient data-management system of a German hospital, restricted to the intensive care unit. To quantify heterogeneity, we discuss and compare different entropy measures. Results: For some pathogen–antibiotic pairs, the consumption-dependent dynamic model for the growth in the proportion of antimicrobial resistance provides acceptable predictions, while for others, the model is less suitable. Cross-resistance and complex interactions with other pathogens and antibiotics may be responsible for this, suggesting that the observed dynamic behavior should be complementary, described using heterogeneity models. Time courses of Shannon entropy, the Antibiotic Heterogeneity Index, and the negative Gini Index correlate positively with the time series of the resistance rate. Thus, an increase in heterogeneity correlates with a decreasing resistance rate. However, a time-delayed cross-correlation of a differential entropy measure with resistance share suggests a functional dependence that can be utilized for antibiotic stewardship. Conclusions: Evidence is provided that the amount of consumption of certain antibiotics drives the corresponding proportions of pathogens’ resistance to these antibiotics; however, the model predictions of these univariable models are generally not sufficiently good, pointing to a more complex interaction dynamics. Therefore, we switch to the level of structural features and show that the degree of constantly mixing of the shares of antibiotic consumption has a control function regarding the incidence of resistance. Controlling differential consumption heterogeneity, therefore, appears to be a feasible operational basis for antibiotic stewardship. Experimental studies are demanded to identify functional dependencies; however, the integration of clinical expertise with model-based prediction appears to be a feasible antibiotic stewardship strategy.
- 15 December 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (12) , 1266
Open AccessAssociation Between Differential Heterogeneity of Antibiotics Consumption and Share of Resistant Pathogens and Its Implication for Antibiotic Stewardship in a German Hospital Intensive Care Unit
Background: The rapid rise in antimicrobial resistance has become one of the 10 most pressing health problems worldwide in recent years. Antibiotic stewardship offers hope in the fight against antibiotic resistance, but it is currently still falling short of expectations. A better understanding of the dynamics of the interaction between antibiotic consumption and the emergence and spread of resistance is urgently needed. Methods: We discuss a simple dynamic model based on a differential equation to describe the increase in the proportion of a pathogen’s antimicrobial resistance to an antibiotic as a function of the time-dependent consumption of that antibiotic. Furthermore, we investigate the association of heterogeneity in the consumption of antibiotics with the rate of resistant pathogens. Data basis is the hospital information system and the patient data-management system of a German hospital, restricted to the intensive care unit. To quantify heterogeneity, we discuss and compare different entropy measures. Results: For some pathogen–antibiotic pairs, the consumption-dependent dynamic model for the growth in the proportion of antimicrobial resistance provides acceptable predictions, while for others, the model is less suitable. Cross-resistance and complex interactions with other pathogens and antibiotics may be responsible for this, suggesting that the observed dynamic behavior should be complementary, described using heterogeneity models. Time courses of Shannon entropy, the Antibiotic Heterogeneity Index, and the negative Gini Index correlate positively with the time series of the resistance rate. Thus, an increase in heterogeneity correlates with a decreasing resistance rate. However, a time-delayed cross-correlation of a differential entropy measure with resistance share suggests a functional dependence that can be utilized for antibiotic stewardship. Conclusions: Evidence is provided that the amount of consumption of certain antibiotics drives the corresponding proportions of pathogens’ resistance to these antibiotics; however, the model predictions of these univariable models are generally not sufficiently good, pointing to a more complex interaction dynamics. Therefore, we switch to the level of structural features and show that the degree of constantly mixing of the shares of antibiotic consumption has a control function regarding the incidence of resistance. Controlling differential consumption heterogeneity, therefore, appears to be a feasible operational basis for antibiotic stewardship. Experimental studies are demanded to identify functional dependencies; however, the integration of clinical expertise with model-based prediction appears to be a feasible antibiotic stewardship strategy.
- Open Access
- 28 October 2025
- Published by MDPI AG in Preprints.org
Association Between Differential Heterogeneity of Antibiotics Consumption and Share of Resistant Pathogens and Its Implication for Antibiotic Stewardship in a German Hospital Intensive Care Unit
Background: The rapid rise in antimicrobial resistance has become one of the 10 most pressing health problems worldwide in recent years. Antimicrobial stewardship is a beacon of hope with regard to measures to combat resistance, but is currently still falling short of expectations. A better understanding of the dynamics of the interaction between antibiotic consumption and the emergence and spread of resistance is urgently needed. Methods: First, we discuss a simple dynamic model based on a differential equation to describe the increase in the proportion of a pathogen’s antimicrobial resistance to an antibiotic as a function of the time-dependent consumption of that antibiotic. Second, we investigate the association of heterogeneity in the consumption of antibiotics with the rate of resistant pathogens. The data basis for this is the hospital information system and the patient data management system of a German hospital, restricted to the intensive care unit. To quantify heterogeneity, we discuss and compare different entropy measures, including differential entropy. Results: For some pathogen-antibiotic pairs, the consumption-dependent dynamic model for the growth in the proportion of antimicrobial resistance provides surprisingly good predictions, while for others, the model is less suitable. Cross-resistance and other complex interactions with other pathogens and antibiotics may be responsible for this, suggesting that the observed dynamic behavior should be complementary described using heterogeneity models. It turns out that the three time courses of Shannon entropy, the so-called Antibiotic Heterogeneity Index, and the negative Gini Index correlate positively with the time series of the resistance rate. Thus, an increase in heterogeneity correlates with a decreasing resistance rate. However, a time delayed cross correlation of a differential entropy measure with resistance share suggests a functional dependence that can be utilized for antibiotic stewardship. Conclusions: We provide evidence that the amount of consumption of certain antibiotics drives the corresponding proportions of pathogens’ resistances to these antibiotics, however, the model predictions of the mono-causal models used are generally not sufficiently good, pointing to a more complex interaction dynamics. Therefore, we switch to the level of structural features and are thus able to show that the degree of constantly mixing the shares of antibiotic consumption has a control function with regard to the incidence of resistance. Controlling differential consumption heterogeneity therefore appears to be a feasible operational basis for antibiotic stewardship. Our results speak in favor of an experimental study or at least inter-clinical comparative studies, as this is the only way to identify functional dependencies. In summary, the integration of clinical expertise with model-based prediction appears to be a feasible antibiotic stewardship strategy.
- 28 October 2025
- Published by MDPI AG in Preprints.org
Open AccessAssociation Between Differential Heterogeneity of Antibiotics Consumption and Share of Resistant Pathogens and Its Implication for Antibiotic Stewardship in a German Hospital Intensive Care Unit
Background: The rapid rise in antimicrobial resistance has become one of the 10 most pressing health problems worldwide in recent years. Antimicrobial stewardship is a beacon of hope with regard to measures to combat resistance, but is currently still falling short of expectations. A better understanding of the dynamics of the interaction between antibiotic consumption and the emergence and spread of resistance is urgently needed. Methods: First, we discuss a simple dynamic model based on a differential equation to describe the increase in the proportion of a pathogen’s antimicrobial resistance to an antibiotic as a function of the time-dependent consumption of that antibiotic. Second, we investigate the association of heterogeneity in the consumption of antibiotics with the rate of resistant pathogens. The data basis for this is the hospital information system and the patient data management system of a German hospital, restricted to the intensive care unit. To quantify heterogeneity, we discuss and compare different entropy measures, including differential entropy. Results: For some pathogen-antibiotic pairs, the consumption-dependent dynamic model for the growth in the proportion of antimicrobial resistance provides surprisingly good predictions, while for others, the model is less suitable. Cross-resistance and other complex interactions with other pathogens and antibiotics may be responsible for this, suggesting that the observed dynamic behavior should be complementary described using heterogeneity models. It turns out that the three time courses of Shannon entropy, the so-called Antibiotic Heterogeneity Index, and the negative Gini Index correlate positively with the time series of the resistance rate. Thus, an increase in heterogeneity correlates with a decreasing resistance rate. However, a time delayed cross correlation of a differential entropy measure with resistance share suggests a functional dependence that can be utilized for antibiotic stewardship. Conclusions: We provide evidence that the amount of consumption of certain antibiotics drives the corresponding proportions of pathogens’ resistances to these antibiotics, however, the model predictions of the mono-causal models used are generally not sufficiently good, pointing to a more complex interaction dynamics. Therefore, we switch to the level of structural features and are thus able to show that the degree of constantly mixing the shares of antibiotic consumption has a control function with regard to the incidence of resistance. Controlling differential consumption heterogeneity therefore appears to be a feasible operational basis for antibiotic stewardship. Our results speak in favor of an experimental study or at least inter-clinical comparative studies, as this is the only way to identify functional dependencies. In summary, the integration of clinical expertise with model-based prediction appears to be a feasible antibiotic stewardship strategy.
- Open Access
- 26 September 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e77077
Computer-Interpretable Quality Indicators for Intensive Care Medicine: Development and Validation Study
Background: Quality indicators (QIs) can help assess intensive care quality, identify potential for improvement, and ultimately enhance patient outcomes. Therefore, the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI) has developed QIs for intensive care medicine. However, variability in how these are technically implemented across health care facilities currently limits their comparability. Objective: The aim of the study is to develop unambiguous computer-interpretable representations of the DIVI QIs for intensive care medicine using Fast Healthcare Interoperability Resources (FHIR) and to establish a replicable process for translating narrative QIs into standardized digital formats. Methods: We first decomposed the narrative DIVI intensive care medicine QIs into two sets of semantic concepts that characterize (1) the targeted patient population and (2) the care aspect specified by each indicator. We mapped the concepts to international vocabularies, defining a supplementary code system for concepts not appropriately represented in existing vocabularies. The decomposed and semantically mapped QIs were then implemented in FHIR using an implementation guide we previously developed to represent clinical practice guideline recommendations. As the translation process holds risks of inducing logical and semantic deviations, the final FHIR representations were back-translated into a narrative form and reviewed with clinical experts, including the authors of the original QIs. The decomposition and semantic mapping were iteratively adjusted based on the experts’ feedback until the results accurately reflected the original intent of the QIs. Results: The 10 DIVI QIs were decomposed into 31 separately measurable indicators, including 9 structural indicators, 17 process indicators, and 5 outcome indicators. All process and outcome indicators were successfully specified as computer-interpretable representations in FHIR. In total, 58 unique medical concepts were used, of which 52 (90%) could be mapped to concepts from international vocabularies. The remaining 6 concepts—mostly intensive care unit–specific scores or roles—were defined in a supplementary code system. Nested Boolean logic and temporal conditions were fully supported using standard FHIR mechanisms. After iterative adjustments, the final representations were approved as accurate representations of the DIVI QIs by the clinical expert panel. Conclusions: Our work demonstrates that the structured process developed here enables the unambiguous, computer-interpretable representation of QIs for intensive care. These representations can be used in automated quality management systems to standardize quality assessments across health care facilities. Our newly defined structured process can serve as a blueprint for similar efforts in other specialties. The here-developed computer-interpretable QIs are openly available for reuse and ongoing maintenance. Future work will focus on piloting these indicators in real-world clinical systems and extending the framework to include structural indicators.
- 26 September 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e77077
Open AccessComputer-Interpretable Quality Indicators for Intensive Care Medicine: Development and Validation Study
Background: Quality indicators (QIs) can help assess intensive care quality, identify potential for improvement, and ultimately enhance patient outcomes. Therefore, the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI) has developed QIs for intensive care medicine. However, variability in how these are technically implemented across health care facilities currently limits their comparability. Objective: The aim of the study is to develop unambiguous computer-interpretable representations of the DIVI QIs for intensive care medicine using Fast Healthcare Interoperability Resources (FHIR) and to establish a replicable process for translating narrative QIs into standardized digital formats. Methods: We first decomposed the narrative DIVI intensive care medicine QIs into two sets of semantic concepts that characterize (1) the targeted patient population and (2) the care aspect specified by each indicator. We mapped the concepts to international vocabularies, defining a supplementary code system for concepts not appropriately represented in existing vocabularies. The decomposed and semantically mapped QIs were then implemented in FHIR using an implementation guide we previously developed to represent clinical practice guideline recommendations. As the translation process holds risks of inducing logical and semantic deviations, the final FHIR representations were back-translated into a narrative form and reviewed with clinical experts, including the authors of the original QIs. The decomposition and semantic mapping were iteratively adjusted based on the experts’ feedback until the results accurately reflected the original intent of the QIs. Results: The 10 DIVI QIs were decomposed into 31 separately measurable indicators, including 9 structural indicators, 17 process indicators, and 5 outcome indicators. All process and outcome indicators were successfully specified as computer-interpretable representations in FHIR. In total, 58 unique medical concepts were used, of which 52 (90%) could be mapped to concepts from international vocabularies. The remaining 6 concepts—mostly intensive care unit–specific scores or roles—were defined in a supplementary code system. Nested Boolean logic and temporal conditions were fully supported using standard FHIR mechanisms. After iterative adjustments, the final representations were approved as accurate representations of the DIVI QIs by the clinical expert panel. Conclusions: Our work demonstrates that the structured process developed here enables the unambiguous, computer-interpretable representation of QIs for intensive care. These representations can be used in automated quality management systems to standardize quality assessments across health care facilities. Our newly defined structured process can serve as a blueprint for similar efforts in other specialties. The here-developed computer-interpretable QIs are openly available for reuse and ongoing maintenance. Future work will focus on piloting these indicators in real-world clinical systems and extending the framework to include structural indicators.
- Top Cited PapersOpen Access
- 7 July 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e69688
Improving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders
Background: Artificial intelligence (AI)–based systems are receiving increasing attention in the health care sector. While the use of AI is well advanced in some medical applications, such as image recognition, it is still in its infancy in others, such as clinical decision support systems (CDSS). Examples of AI-based CDSS can be found in the context of sepsis prediction or antibiotic prescription. Scientific literature indicates that such systems can support physicians in their daily work and lead to improved patient outcomes. Nevertheless, there are various problems and barriers in this context that should be considered. Objective: This study aimed to identify opportunities to optimize AI-based CDSS and their integration into care from the perspective of experts. Methods: Semistructured web-based expert interviews were conducted. Experts representing the perspectives of patients; physicians; caregivers; developers; health insurance representatives; researchers (especially in law and IT); and experts in regulation, market admission and quality management or assurance, and ethics were included. The conversations were recorded and transcribed. Subsequently, a qualitative content analysis was performed. The different approaches to improvement were categorized into groups (“technology,” “data,” “users,” “studies,” “law,” and “general”). These also served as deductive codes. Inductive codes were determined within an internal project workshop. Results: In total, 13 individual and 2 double interviews were conducted with 17 experts. A total of 227 expert statements were included in the analysis. Suggestions were heterogeneous and concerned improvements: (1) in the systems themselves (eg, implementing comprehensive system training involving [future] users; using a comprehensive and high-quality database; considering usability, transparency, and customizability; preventing automation bias through control mechanisms or intelligent design; conducting studies to demonstrate the benefit of the system), (2) on the user side (eg, training [future] physicians could contribute to a more positive attitude and to greater awareness and questioning decision supports suggested by the system and ensuring that the use of the system does not lead to additional work), and (3) in the environment in which the systems are used (eg, increasing the digitalization of the health care system, especially in hospitals; providing transparent public communication about the benefits and risks of AI; providing research funding; clarifying open legal issues, eg, those related to liability; and standardizing and consolidating various approval processes). Conclusions: This study offers several possible strategies for improving AI-based CDSS and their integration into health care. These were found in the areas of “technology,” “data,” “users,” “studies,” “law,” and “general.” Systems, users, and the environment should be taken into account to ensure that the systems are used safely, effectively, and sustainably. Further studies should investigate both the effectiveness of strategies to improve AI-based CDSS and their integration into health care and the accuracy of their match to specific problems. International Registered Report Identifier (IRRID): RR2-10.2196/62704
- 7 July 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e69688
Top Cited PapersOpen AccessImproving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders
Background: Artificial intelligence (AI)–based systems are receiving increasing attention in the health care sector. While the use of AI is well advanced in some medical applications, such as image recognition, it is still in its infancy in others, such as clinical decision support systems (CDSS). Examples of AI-based CDSS can be found in the context of sepsis prediction or antibiotic prescription. Scientific literature indicates that such systems can support physicians in their daily work and lead to improved patient outcomes. Nevertheless, there are various problems and barriers in this context that should be considered. Objective: This study aimed to identify opportunities to optimize AI-based CDSS and their integration into care from the perspective of experts. Methods: Semistructured web-based expert interviews were conducted. Experts representing the perspectives of patients; physicians; caregivers; developers; health insurance representatives; researchers (especially in law and IT); and experts in regulation, market admission and quality management or assurance, and ethics were included. The conversations were recorded and transcribed. Subsequently, a qualitative content analysis was performed. The different approaches to improvement were categorized into groups (“technology,” “data,” “users,” “studies,” “law,” and “general”). These also served as deductive codes. Inductive codes were determined within an internal project workshop. Results: In total, 13 individual and 2 double interviews were conducted with 17 experts. A total of 227 expert statements were included in the analysis. Suggestions were heterogeneous and concerned improvements: (1) in the systems themselves (eg, implementing comprehensive system training involving [future] users; using a comprehensive and high-quality database; considering usability, transparency, and customizability; preventing automation bias through control mechanisms or intelligent design; conducting studies to demonstrate the benefit of the system), (2) on the user side (eg, training [future] physicians could contribute to a more positive attitude and to greater awareness and questioning decision supports suggested by the system and ensuring that the use of the system does not lead to additional work), and (3) in the environment in which the systems are used (eg, increasing the digitalization of the health care system, especially in hospitals; providing transparent public communication about the benefits and risks of AI; providing research funding; clarifying open legal issues, eg, those related to liability; and standardizing and consolidating various approval processes). Conclusions: This study offers several possible strategies for improving AI-based CDSS and their integration into health care. These were found in the areas of “technology,” “data,” “users,” “studies,” “law,” and “general.” Systems, users, and the environment should be taken into account to ensure that the systems are used safely, effectively, and sustainably. Further studies should investigate both the effectiveness of strategies to improve AI-based CDSS and their integration into health care and the accuracy of their match to specific problems. International Registered Report Identifier (IRRID): RR2-10.2196/62704
- Open Access
- 7 May 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Computer-Interpretable Quality Indicators for Intensive Care Medicine: Development and Validation Study (Preprint)
BACKGROUND Quality indicators (QIs) can help assess intensive care quality, identify potential for improvement, and ultimately enhance patient outcomes. Therefore, the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI) has developed QIs for intensive care medicine. However, variability in how these are technically implemented across health care facilities currently limits their comparability. OBJECTIVE The aim of the study is to develop unambiguous computer-interpretable representations of the DIVI QIs for intensive care medicine using Fast Healthcare Interoperability Resources (FHIR) and to establish a replicable process for translating narrative QIs into standardized digital formats. METHODS We first decomposed the narrative DIVI intensive care medicine QIs into two sets of semantic concepts that characterize (1) the targeted patient population and (2) the care aspect specified by each indicator. We mapped the concepts to international vocabularies, defining a supplementary code system for concepts not appropriately represented in existing vocabularies. The decomposed and semantically mapped QIs were then implemented in FHIR using an implementation guide we previously developed to represent clinical practice guideline recommendations. As the translation process holds risks of inducing logical and semantic deviations, the final FHIR representations were back-translated into a narrative form and reviewed with clinical experts, including the authors of the original QIs. The decomposition and semantic mapping were iteratively adjusted based on the experts’ feedback until the results accurately reflected the original intent of the QIs. RESULTS The 10 DIVI QIs were decomposed into 31 separately measurable indicators, including 9 structural indicators, 17 process indicators, and 5 outcome indicators. All process and outcome indicators were successfully specified as computer-interpretable representations in FHIR. In total, 58 unique medical concepts were used, of which 52 (90%) could be mapped to concepts from international vocabularies. The remaining 6 concepts—mostly intensive care unit–specific scores or roles—were defined in a supplementary code system. Nested Boolean logic and temporal conditions were fully supported using standard FHIR mechanisms. After iterative adjustments, the final representations were approved as accurate representations of the DIVI QIs by the clinical expert panel. CONCLUSIONS Our work demonstrates that the structured process developed here enables the unambiguous, computer-interpretable representation of QIs for intensive care. These representations can be used in automated quality management systems to standardize quality assessments across health care facilities. Our newly defined structured process can serve as a blueprint for similar efforts in other specialties. The here-developed computer-interpretable QIs are openly available for reuse and ongoing maintenance. Future work will focus on piloting these indicators in real-world clinical systems and extending the framework to include structural indicators.
- 7 May 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessComputer-Interpretable Quality Indicators for Intensive Care Medicine: Development and Validation Study (Preprint)
BACKGROUND Quality indicators (QIs) can help assess intensive care quality, identify potential for improvement, and ultimately enhance patient outcomes. Therefore, the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI) has developed QIs for intensive care medicine. However, variability in how these are technically implemented across health care facilities currently limits their comparability. OBJECTIVE The aim of the study is to develop unambiguous computer-interpretable representations of the DIVI QIs for intensive care medicine using Fast Healthcare Interoperability Resources (FHIR) and to establish a replicable process for translating narrative QIs into standardized digital formats. METHODS We first decomposed the narrative DIVI intensive care medicine QIs into two sets of semantic concepts that characterize (1) the targeted patient population and (2) the care aspect specified by each indicator. We mapped the concepts to international vocabularies, defining a supplementary code system for concepts not appropriately represented in existing vocabularies. The decomposed and semantically mapped QIs were then implemented in FHIR using an implementation guide we previously developed to represent clinical practice guideline recommendations. As the translation process holds risks of inducing logical and semantic deviations, the final FHIR representations were back-translated into a narrative form and reviewed with clinical experts, including the authors of the original QIs. The decomposition and semantic mapping were iteratively adjusted based on the experts’ feedback until the results accurately reflected the original intent of the QIs. RESULTS The 10 DIVI QIs were decomposed into 31 separately measurable indicators, including 9 structural indicators, 17 process indicators, and 5 outcome indicators. All process and outcome indicators were successfully specified as computer-interpretable representations in FHIR. In total, 58 unique medical concepts were used, of which 52 (90%) could be mapped to concepts from international vocabularies. The remaining 6 concepts—mostly intensive care unit–specific scores or roles—were defined in a supplementary code system. Nested Boolean logic and temporal conditions were fully supported using standard FHIR mechanisms. After iterative adjustments, the final representations were approved as accurate representations of the DIVI QIs by the clinical expert panel. CONCLUSIONS Our work demonstrates that the structured process developed here enables the unambiguous, computer-interpretable representation of QIs for intensive care. These representations can be used in automated quality management systems to standardize quality assessments across health care facilities. Our newly defined structured process can serve as a blueprint for similar efforts in other specialties. The here-developed computer-interpretable QIs are openly available for reuse and ongoing maintenance. Future work will focus on piloting these indicators in real-world clinical systems and extending the framework to include structural indicators.
- Top Cited PapersOpen Access
- 3 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e63377
Problems and Barriers Related to the Use of AI-Based Clinical Decision Support Systems: Interview Study
Background: Digitalization is currently revolutionizing health care worldwide. A promising technology in this context is artificial intelligence (AI). The application of AI can support health care providers in their daily work in various ways. The integration of AI is particularly promising in clinical decision support systems (CDSSs). While the opportunities of this technology are numerous, the problems should not be overlooked. Objective: This study aimed to identify challenges and barriers in the context of AI-based CDSSs from the perspectives of experts across various disciplines. Methods: Semistructured expert interviews were conducted with different stakeholders. These included representatives of patients, physicians and caregivers, developers of AI-based CDSSs, researchers (studying AI in health care and social and health law), quality management and quality assurance representatives, a representative of an ethics committee, a representative of a health insurance fund, and medical product consultants. The interviews took place on the web and were recorded, transcribed, and subsequently subjected to a qualitative content analysis based on the method by Kuckartz. The analysis was conducted using MAXQDA software. Initially, the problems were separated into “general,” “development,” and “clinical use.” Finally, a workshop within the project consortium served to systematize the identified problems. Results: A total of 15 expert interviews were conducted, and 309 expert statements with reference to problems and barriers in the context of AI-based CDSSs were identified. These emerged in 7 problem categories: technology (46/309, 14.9%), data (59/309, 19.1%), user (102/309, 33%), studies (17/309, 5.5%), ethics (20/309, 6.5%), law (33/309, 10.7%), and general (32/309, 10.4%). The problem categories were further divided into problem areas, which in turn comprised the respective problems. Conclusions: A large number of problems and barriers were identified in the context of AI-based CDSSs. These can be systematized according to the point at which they occur (“general,” “development,” and “clinical use”) or according to the problem category (“technology,” “data,” “user,” “studies,” “ethics,” “law,” and “general”). The problems identified in this work should be further investigated. They can be used as a basis for deriving solutions to optimize development, acceptance, and use of AI-based CDSSs. International Registered Report Identifier (IRRID): RR2-10.2196/preprints.62704
- 3 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e63377
Top Cited PapersOpen AccessProblems and Barriers Related to the Use of AI-Based Clinical Decision Support Systems: Interview Study
Background: Digitalization is currently revolutionizing health care worldwide. A promising technology in this context is artificial intelligence (AI). The application of AI can support health care providers in their daily work in various ways. The integration of AI is particularly promising in clinical decision support systems (CDSSs). While the opportunities of this technology are numerous, the problems should not be overlooked. Objective: This study aimed to identify challenges and barriers in the context of AI-based CDSSs from the perspectives of experts across various disciplines. Methods: Semistructured expert interviews were conducted with different stakeholders. These included representatives of patients, physicians and caregivers, developers of AI-based CDSSs, researchers (studying AI in health care and social and health law), quality management and quality assurance representatives, a representative of an ethics committee, a representative of a health insurance fund, and medical product consultants. The interviews took place on the web and were recorded, transcribed, and subsequently subjected to a qualitative content analysis based on the method by Kuckartz. The analysis was conducted using MAXQDA software. Initially, the problems were separated into “general,” “development,” and “clinical use.” Finally, a workshop within the project consortium served to systematize the identified problems. Results: A total of 15 expert interviews were conducted, and 309 expert statements with reference to problems and barriers in the context of AI-based CDSSs were identified. These emerged in 7 problem categories: technology (46/309, 14.9%), data (59/309, 19.1%), user (102/309, 33%), studies (17/309, 5.5%), ethics (20/309, 6.5%), law (33/309, 10.7%), and general (32/309, 10.4%). The problem categories were further divided into problem areas, which in turn comprised the respective problems. Conclusions: A large number of problems and barriers were identified in the context of AI-based CDSSs. These can be systematized according to the point at which they occur (“general,” “development,” and “clinical use”) or according to the problem category (“technology,” “data,” “user,” “studies,” “ethics,” “law,” and “general”). The problems identified in this work should be further investigated. They can be used as a basis for deriving solutions to optimize development, acceptance, and use of AI-based CDSSs. International Registered Report Identifier (IRRID): RR2-10.2196/preprints.62704
- Open Access
- 30 January 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e62704
User-Oriented Requirements for Artificial Intelligence–Based Clinical Decision Support Systems in Sepsis: Protocol for a Multimethod Research Project
Background: Artificial intelligence (AI)–based clinical decision support systems (CDSS) have been developed for several diseases. However, despite the potential to improve the quality of care and thereby positively impact patient-relevant outcomes, the majority of AI-based CDSS have not been adopted in standard care. Possible reasons for this include barriers in the implementation and a nonuser-oriented development approach, resulting in reduced user acceptance. Objective: This research project has 2 objectives. First, problems and corresponding solutions that hinder or support the development and implementation of AI-based CDSS are identified. Second, the research project aims to increase user acceptance by creating a user-oriented requirement profile, using the example of sepsis. Methods: The research project is based on a multimethod approach combining (1) a scoping review, (2) focus groups with physicians and professional caregivers, and (3) semistructured interviews with relevant stakeholders. The research modules mentioned provide the basis for the development of a (4) survey, including a discrete choice experiment (DCE) with physicians. A minimum of 6667 physicians with expertise in the clinical picture of sepsis are contacted for this purpose. The survey is followed by the development of a requirement profile for AI-based CDSS and the derivation of policy recommendations for action, which are evaluated in a (5) expert roundtable discussion. Results: The multimethod research project started in November 2022. It provides an overview of the barriers and corresponding solutions related to the development and implementation of AI-based CDSS. Using sepsis as an example, a user-oriented requirement profile for AI-based CDSS is developed. The scoping review has been concluded and the qualitative modules have been subjected to analysis. The start of the survey, including the DCE, was at the end of July 2024. Conclusions: The results of the research project represent the first attempt to create a comprehensive user-oriented requirement profile for the development of sepsis-specific AI-based CDSS. In addition, general recommendations are derived, in order to reduce barriers in the development and implementation of AI-based CDSS. The findings of this research project have the potential to facilitate the integration of AI-based CDSS into standard care in the long term. International Registered Report Identifier (IRRID): DERR1-10.2196/62704
- 30 January 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e62704
Open AccessUser-Oriented Requirements for Artificial Intelligence–Based Clinical Decision Support Systems in Sepsis: Protocol for a Multimethod Research Project
Background: Artificial intelligence (AI)–based clinical decision support systems (CDSS) have been developed for several diseases. However, despite the potential to improve the quality of care and thereby positively impact patient-relevant outcomes, the majority of AI-based CDSS have not been adopted in standard care. Possible reasons for this include barriers in the implementation and a nonuser-oriented development approach, resulting in reduced user acceptance. Objective: This research project has 2 objectives. First, problems and corresponding solutions that hinder or support the development and implementation of AI-based CDSS are identified. Second, the research project aims to increase user acceptance by creating a user-oriented requirement profile, using the example of sepsis. Methods: The research project is based on a multimethod approach combining (1) a scoping review, (2) focus groups with physicians and professional caregivers, and (3) semistructured interviews with relevant stakeholders. The research modules mentioned provide the basis for the development of a (4) survey, including a discrete choice experiment (DCE) with physicians. A minimum of 6667 physicians with expertise in the clinical picture of sepsis are contacted for this purpose. The survey is followed by the development of a requirement profile for AI-based CDSS and the derivation of policy recommendations for action, which are evaluated in a (5) expert roundtable discussion. Results: The multimethod research project started in November 2022. It provides an overview of the barriers and corresponding solutions related to the development and implementation of AI-based CDSS. Using sepsis as an example, a user-oriented requirement profile for AI-based CDSS is developed. The scoping review has been concluded and the qualitative modules have been subjected to analysis. The start of the survey, including the DCE, was at the end of July 2024. Conclusions: The results of the research project represent the first attempt to create a comprehensive user-oriented requirement profile for the development of sepsis-specific AI-based CDSS. In addition, general recommendations are derived, in order to reduce barriers in the development and implementation of AI-based CDSS. The findings of this research project have the potential to facilitate the integration of AI-based CDSS into standard care in the long term. International Registered Report Identifier (IRRID): DERR1-10.2196/62704
- Open Access
- 5 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Improving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Artificial intelligence (AI)–based systems are receiving increasing attention in the health care sector. While the use of AI is well advanced in some medical applications, such as image recognition, it is still in its infancy in others, such as clinical decision support systems (CDSS). Examples of AI-based CDSS can be found in the context of sepsis prediction or antibiotic prescription. Scientific literature indicates that such systems can support physicians in their daily work and lead to improved patient outcomes. Nevertheless, there are various problems and barriers in this context that should be considered. Objective: This study aimed to identify opportunities to optimize AI-based CDSS and their integration into care from the perspective of experts. Methods: Semistructured web-based expert interviews were conducted. Experts representing the perspectives of patients; physicians; caregivers; developers; health insurance representatives; researchers (especially in law and IT); and experts in regulation, market admission and quality management or assurance, and ethics were included. The conversations were recorded and transcribed. Subsequently, a qualitative content analysis was performed. The different approaches to improvement were categorized into groups (“technology,” “data,” “users,” “studies,” “law,” and “general”). These also served as deductive codes. Inductive codes were determined within an internal project workshop. Results: In total, 13 individual and 2 double interviews were conducted with 17 experts. A total of 227 expert statements were included in the analysis. Suggestions were heterogeneous and concerned improvements: (1) in the systems themselves (eg, implementing comprehensive system training involving [future] users; using a comprehensive and high-quality database; considering usability, transparency, and customizability; preventing automation bias through control mechanisms or intelligent design; conducting studies to demonstrate the benefit of the system), (2) on the user side (eg, training [future] physicians could contribute to a more positive attitude and to greater awareness and questioning decision supports suggested by the system and ensuring that the use of the system does not lead to additional work), and (3) in the environment in which the systems are used (eg, increasing the digitalization of the health care system, especially in hospitals; providing transparent public communication about the benefits and risks of AI; providing research funding; clarifying open legal issues, eg, those related to liability; and standardizing and consolidating various approval processes). Conclusions: This study offers several possible strategies for improving AI-based CDSS and their integration into health care. These were found in the areas of “technology,” “data,” “users,” “studies,” “law,” and “general.” Systems, users, and the environment should be taken into account to ensure that the systems are used safely, effectively, and sustainably. Further studies should investigate both the effectiveness of strategies to improve AI-based CDSS and their integration into health care and the accuracy of their match to specific problems.
- 5 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImproving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Artificial intelligence (AI)–based systems are receiving increasing attention in the health care sector. While the use of AI is well advanced in some medical applications, such as image recognition, it is still in its infancy in others, such as clinical decision support systems (CDSS). Examples of AI-based CDSS can be found in the context of sepsis prediction or antibiotic prescription. Scientific literature indicates that such systems can support physicians in their daily work and lead to improved patient outcomes. Nevertheless, there are various problems and barriers in this context that should be considered. Objective: This study aimed to identify opportunities to optimize AI-based CDSS and their integration into care from the perspective of experts. Methods: Semistructured web-based expert interviews were conducted. Experts representing the perspectives of patients; physicians; caregivers; developers; health insurance representatives; researchers (especially in law and IT); and experts in regulation, market admission and quality management or assurance, and ethics were included. The conversations were recorded and transcribed. Subsequently, a qualitative content analysis was performed. The different approaches to improvement were categorized into groups (“technology,” “data,” “users,” “studies,” “law,” and “general”). These also served as deductive codes. Inductive codes were determined within an internal project workshop. Results: In total, 13 individual and 2 double interviews were conducted with 17 experts. A total of 227 expert statements were included in the analysis. Suggestions were heterogeneous and concerned improvements: (1) in the systems themselves (eg, implementing comprehensive system training involving [future] users; using a comprehensive and high-quality database; considering usability, transparency, and customizability; preventing automation bias through control mechanisms or intelligent design; conducting studies to demonstrate the benefit of the system), (2) on the user side (eg, training [future] physicians could contribute to a more positive attitude and to greater awareness and questioning decision supports suggested by the system and ensuring that the use of the system does not lead to additional work), and (3) in the environment in which the systems are used (eg, increasing the digitalization of the health care system, especially in hospitals; providing transparent public communication about the benefits and risks of AI; providing research funding; clarifying open legal issues, eg, those related to liability; and standardizing and consolidating various approval processes). Conclusions: This study offers several possible strategies for improving AI-based CDSS and their integration into health care. These were found in the areas of “technology,” “data,” “users,” “studies,” “law,” and “general.” Systems, users, and the environment should be taken into account to ensure that the systems are used safely, effectively, and sustainably. Further studies should investigate both the effectiveness of strategies to improve AI-based CDSS and their integration into health care and the accuracy of their match to specific problems.